ESR1 and cancer: While we found greater CD8+ T cells across TNBC cancers compared to the ER+/PR+ cancers at large (Figure 4c), a lack of VCAN identified patients with a similar presence of CD8+ T cells regardless of ER/PR status (Figure 4d).